跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAPRIL 20 TABLET 20 MG - HSA Drug Approval Details
Approvals
/
HSA
/
DAPRIL 20 TABLET 20 MG
Approved
THERAPEUTIC
DAPRIL 20 TABLET 20 MG
MEDOCHEMIE LTD - FACTORY AZ - CYPRUSMEDOCHEMIE (FAR EAST) LTD (ORAL FACILITY) (VIETNAM SOC REP OF)
🇸🇬 Health Sciences Authority
Approval Date
Jun 24, 2002
Approval ID
94021959832aec17
Company
MEDOCHEMIE LTD - FACTORY AZ - CYPRUSMEDOCHEMIE (FAR EAST) LTD (ORAL FACILITY) (VIETNAM SOC REP OF)
Type
Therapeutic
Approval Details
Approval Id
94021959832aec17
Drug Name
DAPRIL 20 TABLET 20 MG
Product Name
DAPRIL 20 TABLET 20 MG
Approval Number
SIN11996P
Approval Date
2002-06-24
Registrant
MEDOCHEMIE SINGAPORE PTE. LTD.
Licence Holder
MEDOCHEMIE SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
C09AA03
Atc Item Name
lisinopril
Pharma Manufacturer Name
MEDOCHEMIE SINGAPORE PTE. LTD.
Active Ingredients
LISINOPRIL DIHYDRATE EQV LISINOPRIL
20 mg
LISINOPRIL DIHYDRATE EQV LISINOPRIL
20 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 24, 2002
Approval ID
94021959832aec17
Type
Therapeutic
Back to HSA Approvals